Your browser doesn't support javascript.
loading
Pharmacogenetic-guided glimepiride therapy in type-2 diabetes mellitus: a cost-effectiveness study.
Fokoun, Cécile; Serrier, Hassan; Rabier, Hugo; Goutelle, Sylvain; Tod, Michel; Bourguignon, Laurent.
Afiliação
  • Fokoun C; Groupement Hospitalier Nord, Service de Pharmacie, Hospices Civils de Lyon, Lyon, France. cecile.fokoun@gmail.com.
  • Serrier H; Pôle de santé publique, Service d'évaluation économique en santé, Hospices Civils de Lyon, Lyon, France.
  • Rabier H; Cellule Innovation, Département de la recherche clinique et de l'innovation, Hospices Civils de Lyon, Lyon, France.
  • Goutelle S; Pôle de santé publique, Service d'évaluation économique en santé, Hospices Civils de Lyon, Lyon, France.
  • Tod M; HESPER Lab, EA 7425, Université Claude Bernard Lyon I, Lyon, France.
  • Bourguignon L; Groupement Hospitalier Nord, Service de Pharmacie, Hospices Civils de Lyon, Lyon, France.
Pharmacogenomics J ; 21(5): 559-565, 2021 10.
Article em En | MEDLINE | ID: mdl-33731883
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Sulfonilureia / Diabetes Mellitus Tipo 2 / Hipoglicemiantes Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Sulfonilureia / Diabetes Mellitus Tipo 2 / Hipoglicemiantes Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article